Integrated therapy reduces serum IgG4 in patients with IgG4-related sclerosing mesenteritis: A Case Report.

IF 6.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Yu-Xiang Wang, Chia-Hao Hsu, Kai-Yun Huang, Chien-Ming Yen, His Chen, Yen-Ying Kung, Ching-Mao Chang
{"title":"Integrated therapy reduces serum IgG4 in patients with IgG4-related sclerosing mesenteritis: A Case Report.","authors":"Yu-Xiang Wang, Chia-Hao Hsu, Kai-Yun Huang, Chien-Ming Yen, His Chen, Yen-Ying Kung, Ching-Mao Chang","doi":"10.1093/qjmed/hcaf163","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the potential effectiveness of Chinese herbal medicine (CHM) as an adjunct to conventional corticosteroid therapy in the management of IgG4-related sclerosing mesenteritis.</p><p><strong>Clinical features and outcome: </strong>A 61-year-old male presented with a two-month history of persistent diarrhea, anorexia, postprandial bloating, and significant weight loss. Diagnostic evaluation, including serum IgG4 measurement and tissue biopsy, confirmed a diagnosis of IgG4-related sclerosing mesenteritis. Despite initial treatment with oral corticosteroids, the patient's serum IgG4 level increased from 1080 mg/dL to 1240 mg/dL, prompting the initiation of integrated therapy with CHM. The patient was treated with a modified CHM regimen primarily composed of San-Tsung-Kuei-Chien-Tang, Zhen-Ren-Huo-Ming-Yin, Wen-Dan-Tang, and Zhu-Ling-Tang. At 217 days after starting CHM, serum IgG4 levels decreased to 606 mg/dL, with marked clinical improvement. Continued CHM therapy further reduced the serum IgG4 concentration to 68 mg/dL, and clinical symptoms remained well controlled without recurrence.</p><p><strong>Conclusions: </strong>Integrated therapy combining CHM with corticosteroid treatment may effectively lower serum IgG4 levels and ameliorate clinical symptoms in IgG4-related sclerosing mesenteritis. Further research is warranted to confirm these findings and clarify the underlying mechanisms.</p>","PeriodicalId":20806,"journal":{"name":"QJM: An International Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":6.4000,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"QJM: An International Journal of Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/qjmed/hcaf163","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To evaluate the potential effectiveness of Chinese herbal medicine (CHM) as an adjunct to conventional corticosteroid therapy in the management of IgG4-related sclerosing mesenteritis.

Clinical features and outcome: A 61-year-old male presented with a two-month history of persistent diarrhea, anorexia, postprandial bloating, and significant weight loss. Diagnostic evaluation, including serum IgG4 measurement and tissue biopsy, confirmed a diagnosis of IgG4-related sclerosing mesenteritis. Despite initial treatment with oral corticosteroids, the patient's serum IgG4 level increased from 1080 mg/dL to 1240 mg/dL, prompting the initiation of integrated therapy with CHM. The patient was treated with a modified CHM regimen primarily composed of San-Tsung-Kuei-Chien-Tang, Zhen-Ren-Huo-Ming-Yin, Wen-Dan-Tang, and Zhu-Ling-Tang. At 217 days after starting CHM, serum IgG4 levels decreased to 606 mg/dL, with marked clinical improvement. Continued CHM therapy further reduced the serum IgG4 concentration to 68 mg/dL, and clinical symptoms remained well controlled without recurrence.

Conclusions: Integrated therapy combining CHM with corticosteroid treatment may effectively lower serum IgG4 levels and ameliorate clinical symptoms in IgG4-related sclerosing mesenteritis. Further research is warranted to confirm these findings and clarify the underlying mechanisms.

综合治疗降低IgG4相关硬化性肠系炎患者血清IgG4: 1例报告
目的:评价中药辅助常规皮质类固醇治疗igg4相关性硬化性肠系炎的潜在疗效。临床特征和结果:一名61岁男性,表现为持续腹泻、厌食、餐后腹胀和明显体重减轻两个月。诊断评估,包括血清IgG4测定和组织活检,证实诊断为IgG4相关的硬化性肠系炎。尽管最初使用口服皮质类固醇治疗,但患者血清IgG4水平从1080 mg/dL上升到1240 mg/dL,促使开始与CHM联合治疗。患者采用改良的中西医结合治疗方案,主要由三总桂健汤、真人火明饮、文丹汤和珠灵汤组成。在CHM开始后217天,血清IgG4水平降至606 mg/dL,临床明显改善。持续CHM治疗进一步降低血清IgG4浓度至68 mg/dL,临床症状得到良好控制,无复发。结论:中西医结合皮质类固醇治疗可有效降低血清IgG4水平,改善IgG4相关性硬化性肠系炎的临床症状。需要进一步的研究来证实这些发现并阐明潜在的机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.90
自引率
5.30%
发文量
263
审稿时长
4-8 weeks
期刊介绍: QJM, a renowned and reputable general medical journal, has been a prominent source of knowledge in the field of internal medicine. With a steadfast commitment to advancing medical science and practice, it features a selection of rigorously reviewed articles. Released on a monthly basis, QJM encompasses a wide range of article types. These include original papers that contribute innovative research, editorials that offer expert opinions, and reviews that provide comprehensive analyses of specific topics. The journal also presents commentary papers aimed at initiating discussions on controversial subjects and allocates a dedicated section for reader correspondence. In summary, QJM's reputable standing stems from its enduring presence in the medical community, consistent publication schedule, and diverse range of content designed to inform and engage readers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信